Robert J Easton's Net Worth
$1.63 Million
Who is Robert J Easton?
Robert J Easton has an estimated net worth of $1.63 Million. This is based on reported shares across multiple companies, which include Enumeral Biomedical Holdings, Inc., CEPHEID, APEX BIOVENTURES ACQUISITION CORP, and COLLAGENEX PHARMACEUTICALS INC.
SEC CIK
Robert J Easton's CIK is 0001189844
Past Insider Trading and Trends
2012 was Robert J Easton's most active year for acquiring shares with 12 total transactions. Robert J Easton's most active month to acquire stocks was the month of March. 2016 was Robert J Easton's most active year for disposing of shares, totalling 11 transactions. Robert J Easton's most active month to dispose stocks was the month of October. 2015 saw Robert J Easton paying a total of $305,099.54 for 109,574 shares, this is the most they've acquired in one year. In 2015 Robert J Easton cashed out on 26,800 shares for a total of $707,842.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enumeral Biomedical Holdings, Inc. No price found
InvestorRobert J Easton owns 480,000 units of Common Stock. In the year 2015 Robert J Easton filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 480K |
$0.13 | $60,000.00 | 480K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CEPHEID No price found
InvestorRobert J Easton used to own units in Common Stock but no longer holds any shares there. From 2013 to 2016 Robert J Easton acquired a total of 110,156 shares in CEPHEID at a cost of $1,243,951.03, Robert also disposed a total of 95,344 shares of CEPHEID equalling to $3,082,142.75.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -90.67K |
—
|
—
|
0
|
Nov 4
| |||
Form 4
| +4.05% | 500 |
$35.35 | $17,674.65 | 12.84K |
Aug 10
| |||
Form 4
| +4.44% | 525 |
$26.73 | $14,033.25 | 12.34K |
May 10
| |||
Form 4
| +17.97% | 1.8K |
—
|
—
| 11.82K |
Apr 26
| |||
Form 4
|
—
|
0
|
$20.20 | -$273,375.00 | 10.02K |
Feb 29
| |||
Form 4
| +5.20% | 495 |
$29.08 | $14,394.60 | 10.02K |
Feb 10
| |||
Form 4
| -4.16% | -3.21K |
$36.02 | -$115,468.28 | 73.86K |
Nov 18 - Nov 20
| |||
Form 4
| -3.41% | -2.72K |
$34.84 | -$94,903.86 | 77.06K |
Nov 13 - Nov 17
| |||
Form 4
| -2.35% | -2.15K |
$35.31 | -$75,135.06 | 89.31K |
Nov 10 - Nov 12
| |||
Form 4
| +3.13% | 277 |
$51.84 | $14,359.68 | 9.12K |
Aug 10
| |||
Form 4
| +2.84% | 244 |
$56.99 | $13,905.56 | 8.84K |
May 10
| |||
Form 4
| +26.47% | 1.8K |
—
|
—
| 8.6K |
Apr 28
| |||
Form 4
| +36.00% | 1.8K |
—
|
—
| 6.8K |
Apr 22
| |||
Form 4
| +5.26% | 250 |
$57.45 | $14,362.50 | 5K |
Feb 10
| |||
Form 4
|
—
|
0
|
$38.24 | -$459,717.50 | 4.75K |
Feb 2
| |||
Form 4
| +0.33% | 272 |
$52.80 | $14,361.60 | 81.97K |
Nov 10
| |||
Form 4
| +0.46% | 372 |
$38.70 | $14,396.40 | 81.7K |
Aug 10
| |||
Form 4
| +0.40% | 323 |
$42.56 | $13,746.88 | 81.33K |
May 10
| |||
Form 4
| +1.08% | 867 |
—
|
—
| 81K |
Apr 30
| |||
Form 4
|
—
|
0
|
$28.72 | -$421,783.75 | 80.14K |
Apr 22
| |||
Form 4
| +0.35% | 282 |
$50.10 | $14,128.20 | 80.14K |
Feb 10
| |||
Form 4
| +0.43% | 339 |
$41.57 | $14,092.23 | 79.86K |
Nov 10
| |||
Form 4
| +0.50% | 393 |
$35.97 | $14,136.21 | 79.52K |
Aug 10
| |||
Form 4
|
—
|
0
|
$21.83 | -$197,674.50 | 79.12K |
Aug 21
| |||
Form 4
| +0.43% | 342 |
$39.96 | $13,666.32 | 79.12K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
| +1.35% | 1.05K |
—
|
—
| 78.78K |
Apr 24
| |||
Form 4
| +0.50% | 390 |
$23.02 | -$321,842.10 | 77.73K |
Feb 8 - Feb 10
| |||
Form 4
| +0.63% | 482 |
$29.45 | $14,194.90 | 77.34K |
Nov 10
| |||
Form 4
|
—
|
0
|
$19.49 | -$182,067.00 | 76.86K |
Oct 22
| |||
Form 4
|
—
|
0
|
$21.01 | -$237,150.00 | 76.86K |
Aug 30
| |||
Form 4
| +0.51% | 390 |
$37.83 | $14,753.70 | 76.86K |
Aug 10
| |||
Form 4
| +0.46% | 347 |
$37.49 | $13,009.03 | 76.47K |
May 10
| |||
Form 4
| +1.40% | 1.05K |
—
|
—
| 76.12K |
Apr 24 - Apr 26
| |||
Form 4
| +1.90% | 1.4K |
$34.35 | $47,983.70 | 75.07K |
May 10 - Feb 10
| |||
Form 4
| +6.79% | 5K |
$2.92 | $14,600.00 | 78.68K |
Jan 10
| |||
Form 4
|
—
|
0
|
$20.33 | -$174,100.00 | 73.68K |
Oct 25
| |||
Form 4
| +1.45% | 1.05K |
—
|
—
| 73.68K |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
| +0.30% | 216 |
$24.87 | $5,371.92 | 72.63K |
Feb 10
| |||
Form 4
| +7.42% | 5K |
$2.92 | $14,600.00 | 72.41K |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
| +8.01% | 5K |
$20.68 | $103,400.00 | 67.41K |
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APEX BIOVENTURES ACQUISITION CORP No price found
EVP, Strategy and Planning
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COLLAGENEX PHARMACEUTICALS INC No price found
InvestorRobert J Easton owns 45,859 units of Common Stock.acquired a total of 25,000 shares in COLLAGENEX PHARMACEUTICALS INC at a cost of $274,850.00, Robert also disposed a total of 10,000 shares of COLLAGENEX PHARMACEUTICALS INC equalling to $130,523.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +48.61% | 15K |
$9.75 | $146,250.00 | 45.86K |
Nov 9
| |||
Form 4
| -24.47% | -10.00K |
$13.05 | -$130,523.00 | 30.86K |
Sep 18
| |||
Form 4
| +32.41% | 10K |
$12.86 | $128,600.00 | 40.86K |
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||